VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Tumor iNOS predicts poor survival for stage III melanoma patients.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Tumor iNOS predicts poor survival for stage III melanoma patients.
Tumor iNOS predicts poor survival for stage III melanoma patients. Int J Cancer. 2006 Aug 15; 119(4):861-6.
View in:
PubMed
subject areas
Adolescent
Adult
Aged
Aged, 80 and over
Biomarkers, Tumor
Female
Gene Expression Regulation, Enzymologic
Gene Expression Regulation, Neoplastic
Humans
Male
Melanoma
Middle Aged
Neoplasm Staging
Nitric Oxide Synthase Type II
Survival Rate
authors with profiles
ELIZABETH A GRIMM
SUHENDAN EKMEKCIOGLU
VICTOR PRIETO